Affective symptoms and regional cerebral tau burden in early-stage Alzheimer's disease

被引:10
|
作者
Tommasi, Nicole S. [1 ,2 ]
Gonzalez, Christopher [1 ,2 ,3 ]
Briggs, Danielle [1 ,2 ,3 ]
Properzi, Michael J. [3 ]
Gatchel, Jennifer R. [4 ,5 ]
Marshall, Gad A. [1 ,2 ,3 ]
机构
[1] Harvard Med Sch, Ctr Alzheimer Res & Treatment, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Neurol, Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA
[4] Harvard Med Sch, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA
[5] Harvard Med Sch, Div Geriatr Psychiat, McLean Hosp, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
affective symptoms; Alzheimer' s disease; amyloid; mild cognitive impairment; neuropsychiatric symptoms; positron emission tomography; tau; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRIC SYMPTOMS; INSTRUMENTAL ACTIVITIES; AMYLOID-BETA; APATHY; ACCUMULATION; PROGRESSION; INVENTORY; DEMENTIA; PSYCHOPATHOLOGY;
D O I
10.1002/gps.5530
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective Neuropsychiatric symptoms (NPS) are often present in individuals with mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia. NPS are associated with structural and functional changes in the brain such as atrophy, regional hypometabolism, and hypoperfusion, considered proxies of neurodegeneration. Our objective was to evaluate the association between NPS and regional cerebral tau burden, a more direct representation of neurodegeneration, in cognitively normal (CN), MCI, and AD dementia individuals. Methods Cross-sectional NPS were assessed using the Neuropsychiatric Inventory (NPI) in 410 CN, 199 MCI, and 61 AD dementia participants who underwent flortaucipir tau positron emission tomography as part of the AD Neuroimaging Initiative (ADNI). Total NPI score and two factors of NPS (affective and hyperactive) were used in analyses. Linear regression models with backward elimination were employed with NPI as dependent variable and regional tau or tau-amyloid interaction as predictor of interest. Covariates included education, age, sex, Rey Auditory Verbal Learning Test Total Learning, and Trail Making Test B. Results There were significant associations (p < 0.05) between the NPI variables (total score, Affective factor) and entorhinal and precuneus tau across all participants. These associations were also significant for the tau-amyloid interaction. These effects were significant in cognitively symptomatic participants (MCI and AD dementia), but not in CN participants. Conclusions Increased tau burden in the entorhinal and precuneus cortices was modestly associated with greater NPS in MCI and AD dementia. Further evaluation of NPS and their effect on early-stage AD could aid in finding new interventions and slowing disease progression.
引用
收藏
页码:1050 / 1058
页数:9
相关论文
共 50 条
  • [21] Regional cerebral tau predicts decline in everyday functioning across the Alzheimer's disease spectrum
    Dubbelman, Mark A. J.
    Mimmack, Kayden J. H.
    Sprague, Emily H. E.
    Amariglio, Rebecca E.
    Vannini, Patrizia A.
    Marshall, Gad A.
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [22] Evidence of Altered Corticomotor System Connectivity in Early-Stage Alzheimer's Disease
    Vidoni, Eric D.
    Thomas, George P.
    Honea, Robyn A.
    Loskutova, Natalia
    Burns, Jeffrey M.
    JOURNAL OF NEUROLOGIC PHYSICAL THERAPY, 2012, 36 (01): : 8 - 16
  • [23] Rethinking the Food and Drug Administration's 2013 guidance on developing drugs for early-stage Alzheimer's disease
    Schneider, Lon S.
    ALZHEIMERS & DEMENTIA, 2014, 10 (02) : 247 - 250
  • [24] Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021
    Porsteinsson, A. P.
    Isaacson, R. S.
    Knox, Sean
    Sabbagh, M. N.
    Rubino, I.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2021, 8 (03): : 371 - 386
  • [25] Neuropsychiatric symptoms as early manifestation of Alzheimer's disease
    Matuskova, V
    Nikolai, T.
    Markova, H.
    Cechova, K.
    Laczo, J.
    Hort, J.
    Vyhnalek, M.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (01) : 64 - 72
  • [26] Depressive symptoms and regional cerebral blood flow in Alzheimer's disease
    Terada, Seishi
    Oshima, Etsuko
    Sato, Shuhei
    Ikeda, Chikako
    Nagao, Shigeto
    Hayashi, Satoshi
    Hayashibara, Chinatsu
    Yokota, Osamu
    Uchitomi, Yosuke
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2014, 221 (01) : 86 - 91
  • [27] Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease
    Gatchel, Jennifer R.
    Donovan, Nancy J.
    Locascio, Joseph J.
    Becker, J. Alex
    Rentz, Dorene M.
    Sperling, Reisa A.
    Johnson, Keith A.
    Marshall, Gad A.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (07) : 683 - 693
  • [28] Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer's Disease: A Case Series
    Dhaynaut, Maeva
    Sprugnoli, Giulia
    Cappon, Davide
    Macone, Joanna
    Sanchez, Justin S.
    Normandin, Marc D.
    Guehl, Nicolas J.
    Koch, Giacomo
    Paciorek, Rachel
    Connor, Ann
    Press, Daniel
    Johnson, Keith
    Pascual-Leone, Alvaro
    El Fakhri, Georges
    Santarnecchi, Emiliano
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 85 (04) : 1667 - 1676
  • [29] Anatomical Correlates of the Neuropsychiatric Symptoms in Alzheimer's Disease
    Hu, Xiaochen
    Meiberth, Dix
    Newport, Beate
    Jessen, Frank
    CURRENT ALZHEIMER RESEARCH, 2015, 12 (03) : 266 - 277
  • [30] The reporting of neuropsychiatric symptoms in electronic health records of individuals with Alzheimer's disease: a natural language processing study
    Eikelboom, Willem S.
    Singleton, Ellen H.
    van den Berg, Esther
    de Boer, Casper
    Coesmans, Michiel
    Goudzwaard, Jeannette A.
    Vijverberg, Everard G. B.
    Pan, Michel
    Gouw, Cornalijn
    Mol, Merel O.
    Gillissen, Freek
    Fieldhouse, Jay L. P.
    Pijnenburg, Yolande A. L.
    van der Flier, Wiesje M.
    van Swieten, John C.
    Ossenkoppele, Rik
    Kors, Jan A.
    Papma, Janne M.
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)